|
1
|
Pascual-Pasto G, Bazan-Peregrino M,
Olaciregui NG, Restrepo-Perdomo CA, Mato-Berciano A, Ottaviani D,
Weber K, Correa G, Paco S, Vila-Ubach M, et al: Therapeutic
targeting of the RB1 pathway in retinoblastoma with the oncolytic
adenovirus VCN-01. Sci Transl Med. 11(11)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chantada GL, Qaddoumi I, Canturk S, Khetan
V, Ma Z, Kimani K, Yeniad B, Sultan I, Sitorus RS, Tacyildiz N, et
al: Strategies to manage retinoblastoma in developing countries.
Pediatr Blood Cancer. 56:341–348. 2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Canturk S, Qaddoumi I, Khetan V, Ma Z,
Furmanchuk A, Antoneli CB, Sultan I, Kebudi R, Sharma T,
Rodriguez-Galindo C, et al: Survival of retinoblastoma in
less-developed countries impact of socioeconomic and health-related
indicators. Br J Ophthalmol. 94:1432–1436. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Errico A: Cancer therapy: Retinoblastoma -
chemotherapy increases the risk of secondary cancer. Nat Rev Clin
Oncol. 11(623)2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Shields CL, Say EA, Pointdujour-Lim R, Cao
C, Jabbour PM and Shields JA: Rescue intra-arterial chemotherapy
following retinoblastoma recurrence after initial intra-arterial
chemotherapy. J Fr Ophtalmol. 38:542–549. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rao AKDM, Rajkumar T and Mani S:
Perspectives of long non-coding RNAs in cancer. Mol Biol Rep.
44:203–218. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li S, Wen D, Che S, Cui Z, Sun Y, Ren H
and Hao J: Knockdown of long noncoding RNA 00152 (LINC00152)
inhibits human retinoblastoma progression. OncoTargets Ther.
11:3215–3223. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang L, Zhang L, Lu L and Wang Y: Long
noncoding RNA SNHG16 sponges miR-182-5p and miR-128-3p to promote
retinoblastoma cell migration and invasion by targeting LASP1.
OncoTargets Ther. 12:8653–8662. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wu XZ, Cui HP, Lv HJ and Feng L: Knockdown
of lncRNA PVT1 inhibits retinoblastoma progression by sponging
miR-488-3p. Biomed Pharmacother. 112(108627)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang L, Wang C, Wu T and Sun F: Long
non-coding RNA TP73-AS1 promotes TFAP2B-mediated proliferation,
metastasis and invasion in retinoblastoma via decoying of
miRNA-874-3p. J Cell Commun Signal. 14:193–205. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chang W, Wang Y, Li W and Geng Z: Long
non-coding RNA myocardial infarction associated transcript promotes
the proliferation of cholangiocarcinoma cells by targeting
miR-551b-3p/CCND1 axis. Clin Exp Pharmacol Physiol. 47:1067–1075.
2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhou Z, Zhang S and Xiong Y: Long
noncoding RNA MIAT promotes non-small cell lung cancer progression
by sponging miR-149-5p and regulating FOXM1 expression. Cancer Cell
Int. 20(348)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li F, Li H, Li S, Lv B, Shi J, Yan H,
Zhang H and He Y: Long Non-coding RNA MIAT mediates non-small cell
lung cancer development through regulating the miR-128-3p/PELI3
Axis. Biochem Genet. 58:867–882. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang L, Ge S and Cao B: Long non-coding
RNA MIAT promotes cervical cancer proliferation and migration. J
Biochem. 168:183–190. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhou S, Xu A, Song T, Gao F, Sun H and
Kong X: lncRNA MIAT regulates cell growth, migration, and invasion
through sponging miR-150-5p in ovarian cancer. Cancer Biother
Radiopharm. 35:650–660. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Liu Y, Peng H, Shen Y, Da R, Tian A and
Guo X: Downregulation of long noncoding RNA myocardial infarction
associated transcript suppresses cell proliferation, migration,
invasion, and glycolysis by regulation of miR-488-3p/IGF1R pathway
in colorectal cancer. Cancer Biother Radiopharm: Oct 21, 2020 (Epub
ahead of print). doi: 10.1089/cbr.2020.3671.
|
|
17
|
Sha M, Lin M, Wang J, Ye J, Xu J, Xu N and
Huang J: Long non-coding RNA MIAT promotes gastric cancer growth
and metastasis through regulation of miR-141/DDX5 pathway. J Exp
Clin Cancer Res. 37(58)2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lu TX and Rothenberg ME: MicroRNA. J
Allergy Clin Immunol. 141:1202–1207. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liu Y, Li H, Liu Y and Zhu Z: MiR-22-3p
targeting alpha-enolase 1 regulates the proliferation of
retinoblastoma cells. Biomed Pharmacother. 105:805–812.
2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wang L, Yang D, Tian R and Zhang H: NEAT1
promotes retinoblastoma progression via modulating miR-124. J Cell
Biochem. 120:15585–15593. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Han N, Zuo L, Chen H, Zhang C, He P and
Yan H: Long non-coding RNA homeobox A11 antisense RNA (HOXA11-AS)
promotes retinoblastoma progression via sponging miR-506-3p.
OncoTargets Ther. 12:3509–3517. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Xu L, Li W, Shi Q, Wang M, Li H, Yang X
and Zhang J: MicroRNA 936 inhibits the malignant phenotype of
retinoblastoma by directly targeting HDAC9 and deactivating the
PI3K/AKT pathway. Oncol Rep. 43:635–645. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang S, Du S, Lv Y, Zhang F and Wang W:
MicroRNA-665 inhibits the oncogenicity of retinoblastoma by
directly targeting high-mobility group box 1 and inactivating the
Wnt/β-catenin pathway. Cancer Manag Res. 11:3111–3123.
2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhang S, Long J and Hu Y: Long noncoding
RNA LINC00205 enhances the malignant characteristics of
retinoblastoma by acting as a molecular sponge of microRNA-665 and
consequently increasing HMGB1 expression. Biochem Biophys Res
Commun. 526:396–403. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hu S, Ran Y, Chen W, Zhang Y and Xu Y:
MicroRNA-326 inhibits cell proliferation and invasion, activating
apoptosis in hepatocellular carcinoma by directly targeting LIM and
SH3 protein 1. Oncol Rep. 38:1569–1578. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yan P, Liu J, Zhou R, Lin C, Wu K, Yang S,
Yang S, Zhou J, Xu L, Wang H, et al: LASP1 interacts with N-WASP to
activate the Arp2/3 complex and facilitate colorectal cancer
metastasis by increasing tumour budding and worsening the pattern
of invasion. Oncogene. 39:5743–5755. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wang S, Qiu J, Wang L, Wu Z, Zhang X, Li Q
and Jiang F: Long non-coding RNA LINC01207 promotes prostate cancer
progression by downregulating microRNA-1972 and upregulating LIM
and SH3 protein 1. IUBMB Life. 72:1960–1975. 2020.PubMed/NCBI View
Article : Google Scholar
|
|
28
|
Sui Y, Zhang X, Yang H, Wei W and Wang M:
MicroRNA-133a acts as a tumour suppressor in breast cancer through
targeting LASP1. Oncol Rep. 39:473–482. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Song X, Jin Y, Yan M, Zhang Y and Chen B:
MicroRNA-342-3p functions as a tumor suppressor by targeting LIM
and SH3 protein 1 in oral squamous cell carcinoma. Oncol Lett.
17:688–696. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Liu W, Wang ZL, Wang C and Ai ZL: Long
non-coding RNA MIAT promotes papillary thyroid cancer progression
through upregulating LASP1. Cancer Cell Int. 19(194)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wang JX, Yang Y and Li K: Long noncoding
RNA DANCR aggravates retinoblastoma through miR-34c and miR-613 by
targeting MMP-9. J Cell Physiol. 233:6986–6995. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Shang W, Yang Y, Zhang J and Wu Q: Long
noncoding RNA BDNF-AS is a potential biomarker and regulates cancer
development in human retinoblastoma. Biochem Biophys Res Commun.
497:1142–1148. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yan G, Su Y, Ma Z, Yu L and Chen N: Long
Noncoding RNA LINC00202 promotes tumor progression by sponging
miR-3619-5p in retinoblastoma. Cell Struct Funct. 44:51–60.
2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hu C, Liu S, Han M, Wang Y and Xu C:
Knockdown of lncRNA XIST inhibits retinoblastoma progression by
modulating the miR-124/STAT3 axis. Biomed Pharmacother.
107:547–554. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Du Z, Sun T, Hacisuleyman E, Fei T, Wang
X, Brown M, Rinn JL, Lee MG, Chen Y, Kantoff PW, et al: Integrative
analyses reveal a long noncoding RNA-mediated sponge regulatory
network in prostate cancer. Nat Commun. 7(10982)2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Hao F, Mou Y, Zhang L, Wang S and Yang Y:
LncRNA AFAP1-AS1 is a prognostic biomarker and serves as oncogenic
role in retinoblastoma. Biosci Rep. 38(38)2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Zhao J, Yang T, Ji J, Zhao F, Li C and Han
X: RHPN1-AS1 promotes cell proliferation and migration via
miR-665/Akt3 in ovarian cancer. Cancer Gene Ther. 28:33–41.
2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ouyang S, Zhou X, Chen Z, Wang M, Zheng X
and Xie M: LncRNA BCAR4, targeting to miR-665/STAT3 signaling,
maintains cancer stem cells stemness and promotes tumorigenicity in
colorectal cancer. Cancer Cell Int. 19(72)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wu KZ, Zhang CD, Zhang C, Pei JP and Dai
DQ: miR-665 suppresses the epithelial-mesenchymal transition and
progression of gastric cancer by targeting CRIM1. Cancer Manag Res.
12:3489–3501. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Orth MF, Cazes A, Butt E and Grunewald TG:
An update on the LIM and SH3 domain protein 1 (LASP1): A versatile
structural, signaling, and biomarker protein. Oncotarget. 6:26–42.
2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Li Z, Chen Y, Wang X, Zhang H, Zhang Y,
Gao Y, Weng M, Wang L, Liang H, Li M, et al: LASP-1 induces
proliferation, metastasis and cell cycle arrest at the G2/M phase
in gallbladder cancer by down-regulating S100P via the PI3K/AKT
pathway. Cancer Lett. 372:239–250. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Zheng J, Wang F, Lu S and Wang X: LASP-1,
regulated by miR-203, promotes tumor proliferation and
aggressiveness in human non-small cell lung cancer. Exp Mol Pathol.
100:116–124. 2016.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Zhao L, Wang H, Liu C, Liu Y, Wang X, Wang
S, Sun X, Li J, Deng Y, Jiang Y, et al: Promotion of colorectal
cancer growth and metastasis by the LIM and SH3 domain protein 1.
Gut. 59:1226–1235. 2010.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Grunewald TG, Kammerer U, Winkler C,
Schindler D, Sickmann A, Honig A and Butt E: Overexpression of
LASP-1 mediates migration and proliferation of human ovarian cancer
cells and influences zyxin localisation. Br J Cancer. 96:296–305.
2007.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Liu W, Wang Z, Wang C and Ai Z: Long
non-coding RNA MIAT promotes papillary thyroid cancer progression
through upregulating LASP1. Cancer Cell Int. 19(194)2019.PubMed/NCBI View Article : Google Scholar
|
